Signaling Pathways
| Product Name | CAS No. | Specification | Application | Registration |
| 7-Epi-Paclitaxel (7-Epitaxol) | 105454-04-4 | 98+% | Paclitaxel EP Impurity E | N/A |
| Cidofovir Dihydrate | 149394-66-1 | 98+% | ||
| Epothilone B (Patupilone) | 152044-54-7 | 98+% | Antineoplastic Agent | |
| Cabazitaxel | 183133-96-2 | 98+% | Microtubule Associated inhibitor | Autophagy activator | |
| Stiripentol (BCX 2600) | 49763-96-4 | 98+% | ||
| Belinostat (PXD101) | 866323-14-0 | 99+% | Antineoplastic Agent | |
| Nintedanib Ethanesulfonate Salt | 656247-18-6 | 99+% | VEGFR inhibitor | FGFR inhibitor | PDGFR inhibitor | Src inhibitor | |
| Bexarotene (LGD-1069) | 153559-49-0 | 99+% | Oncology | |
| Mitomycin C (Ametycine) | 50-07-7 | 99+% | Oncology | |
| Calcitriol | 32222-06-3 | 98+% | ||
| Caspofungin Acetate (L 743872) | 179463-17-3 | 99+% | ||
| Combretastatin A4 Disodium Phosphate (CA4P) | 168555-66-6 | 98+% | ||
| Bortezomib | 179324-69-7 | 99+% | Proteasome inhibitor | Autophagy inhibitor | ERK activator | NF-κB inhibitor | Cathepsin B inhibitor | Cysteine Protease inhibitor | |
| Nelarabine (506U78) | 121032-29-9 | 99+% | Anti-cancer | DNA/RNA Synthesis inhibitor | |
| Abiraterone Acetate (CB7630) | 154229-18-2 | 98+% |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies
- Bioactive Small Molecules
- Screening Compounds
- Stable Isotope Labelled Compounds
- COVID-19 Related Inhibitors
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn